Effect of methyl jasmonate on the aroma of Sangiovese grapes and wines
-
Add time:08/24/2019 Source:sciencedirect.com
Methyl jasmonate (MeJA) was applied in a vineyard on leaves and grape clusters of cv Sangiovese to test its ability to stimulate the production of aromas and identify the main genes involved in the biosynthetic pathways switched on by the elicitor.MeJA application led to a delay in grape technological maturity and a significant increase in the concentration of several berry aroma classes (about twice the total aroma: from around 3 to 6 μg/g of berry). Of these, monoterpenes showed the most significant increase. An analysis of the expression of terpenoid biosynthesis genes confirmed that the MeJA application activated the related biosynthetic pathway. The expression of all the TPS genes analyzedwas higher in samples treated with MeJA. Also the wines produced by microvinification of Sangiovese treated and untreated grapes showed a rise in the aroma concentration as in berries, with an important impact on longevity and sensorial characters of wines.
We also recommend Trading Suppliers and Manufacturers of 2-(Methyl(2-phenoxyethyl)aMino)ethanol (cas 113824-76-3). Pls Click Website Link as below: cas 113824-76-3 suppliers
Prev:Synthesis and α-adrenoreceptor blocking properties of phenoxybenzamine-related (2-chloroethyl)-(2,3-dihydrobenzo-[1,4]dioxin-2-ylmethyl)-(2-phenoxyethyl) amines
Next:Benzoxadiazocines, benzothiadiazocines and benzotriazocines-V : The synthesis of some 2-amino-6-methyl- and 2-amino-6-phenyl-5,6-dihydro-4h-3,1,6-benzothiadiazocines) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Benzoxadiazocines, benzothiadiazocines and benzotriazocines-V : The synthesis of some 2-amino-6-methyl- and 2-amino-6-phenyl-5,6-dihydro-4h-3,1,6-benzothiadiazocines08/25/2019
- Synthesis and α-adrenoreceptor blocking properties of phenoxybenzamine-related (2-chloroethyl)-(2,3-dihydrobenzo-[1,4]dioxin-2-ylmethyl)-(2-phenoxyethyl) amines08/23/2019
- Discovery of 9-(1-phenoxyethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as oral PI3Kβ inhibitors, useful as antiplatelet agents08/22/2019


